Skip to main content

Development to Chronic Pancreatitis

  • Chapter
  • First Online:
Autoimmune Pancreatitis

Abstract

The long-term prognosis and outcomes of autoimmune pancreatitis (AIP) remain unclear. Because patients with AIP respond favorably to prednisolone (PSL) therapy in clinical, serological, imaging, and pathological settings [1–5], the disease was previously believed to be an acute condition that did not progress to an advanced stage of chronic pancreatitis. However, over the last decade, it has been revealed that some patients with AIP could progress to pancreatic stone formation, pancreatic atrophy, and/or irregular dilatation of the main pancreatic duct (MPD), which may raise new questions about whether AIP can progress to confirmed chronic pancreatitis or not.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Kamisawa T, Shimosegawa T, Okazaki K, Nishino T, Watanabe H, Kanno A. Standard steroid treatment for autoimmune pancreatitis. Gut. 2009;58:1504–7.

    Article  CAS  PubMed  Google Scholar 

  2. Kamisawa T, Okazaki K, Kawa S, Shimosegawa T, Tanaka M. Japanese consensus guidelines for management of autoimmune pancreatitis: III. Treatment and prognosis of AIP. J Gastroenterol. 2010;45:471–7.

    Article  CAS  PubMed  Google Scholar 

  3. Hart PA, Kamisawa T, Brugge WR, Chung JB, Culver EL, Czako L, et al. Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis. Gut. 2013;62:1771–6.

    Article  PubMed Central  PubMed  Google Scholar 

  4. Song MH, Kim MH, Lee SK, Seo DW, Lee SS, Han J, et al. Regression of pancreatic fibrosis after steroid therapy in patients with autoimmune chronic pancreatitis. Pancreas. 2005;30:83–6.

    Article  PubMed  Google Scholar 

  5. Ko SB, Mizuno N, Yatabe Y, Yoshikawa T, Ishiguro H, Yamamoto A. Corticosteroids correct aberrant CFTR localization in the duct and regenerate acinar cells in autoimmune pancreatitis. Gastroenterology. 2010;138:1988–96.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  6. Takayama M, Hamano H, Ochi Y, Saegusa H, Komatsu K, Muraki T, et al. Recurrent attacks of autoimmune pancreatitis result in pancreatic stone formation. Am J Gastroenterol. 2004;99:932–7.

    Article  PubMed  Google Scholar 

  7. Kawa S, Hamano H, Ozaki Y, Ito T, Kodama R, Chou Y, et al. Long-term follow-up of autoimmune pancreatitis: characteristics of chronic disease and recurrence. Clin Gastroenterol Hepatol. 2009;7:S18–22.

    Article  CAS  PubMed  Google Scholar 

  8. Takuma K, Kamisawa T, Tabata T, Inaba Y, Egawa N, Igarashi Y. Short-term and long-term outcomes of autoimmune pancreatitis. Eur J Gastroenterol Hepatol. 2011;23:146–52.

    Article  CAS  PubMed  Google Scholar 

  9. Suzuki K, Itoh S, Nagasaka T, Ogawa H, Ota T, Naganawa S. CT findings in autoimmune pancreatitis: assessment using multiphase contrast-enhanced multisection CT. Clin Radiol. 2010;65:735–43.

    Article  CAS  PubMed  Google Scholar 

  10. Sah RP, Pannala R, Chari ST, Sugumar A, Clain JE, Levy MJ, et al. Prevalence, diagnosis, and profile of autoimmune pancreatitis presenting with features of acute or chronic pancreatitis. Clin Gastroenterol Hepatol. 2010;8:91–6.

    Article  PubMed  Google Scholar 

  11. Takada H, Nakazawa T, Ohara H, Ando T, Hayashi K, Naito I, et al. Role of osteopontin in calcification in autoimmune pancreatitis. Dig Dis Sci. 2009;54:793–801.

    Article  CAS  PubMed  Google Scholar 

  12. Nakazawa T, Ohara H, Sano H, Ando T, Imai H, Takada H, et al. Difficulty in diagnosing autoimmune pancreatitis by imaging findings. Gastrointest Endosc. 2007;65:99–108.

    Article  PubMed  Google Scholar 

  13. Nishino T, Toki F, Oyama H, Shimizu K, Shiratori K. Long-term outcome of autoimmune pancreatitis after oral prednisolone therapy. Intern Med. 2006;45:497–501.

    Article  PubMed  Google Scholar 

  14. Maire F, Le Baleur Y, Rebours V, Vullierme MP, Couvelard A, Voitot H, et al. Outcome of patients with type 1 or 2 autoimmune pancreatitis. Am J Gastroenterol. 2011;106:151–6.

    Article  CAS  PubMed  Google Scholar 

  15. Yoshida K, Toki F, Takeuchi T, Watanabe S, Shiratori K, Hayashi N. Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci. 1995;40:1561–8.

    Article  CAS  PubMed  Google Scholar 

  16. Kawa S, Hamano H. Clinical features of autoimmune pancreatitis. J Gastroenterol. 2007;42 Suppl 18:9–14.

    Article  PubMed  Google Scholar 

  17. Muraki T, Hamano H, Ochi Y, Komatsu K, Komiyama Y, Arakura N, et al. Autoimmune pancreatitis and complement activation system. Pancreas. 2006;32:16–21.

    Article  PubMed  Google Scholar 

  18. Maruyama M, Arakura N, Ozaki Y, Watanabe T, Ito T, Yoneda S, et al. Risk factors for pancreatic stone formation in autoimmune pancreatitis over a long-term course. J Gastroenterol. 2012;47:553–60.

    Article  CAS  PubMed  Google Scholar 

  19. Hirano K, Tada M, Isayama H, Watanabe T, Saito T, Uchino R, et al. High alcohol consumption increases the risk of pancreatic stone formation and pancreatic atrophy in autoimmune pancreatitis. Pancreas. 2013;42(3):502–5.

    Article  PubMed  Google Scholar 

  20. Zhang X, Li W, Jiang L, Guo Y, Wang X. Clinical analysis of 36 cases of autoimmune pancreatitis in China. PLoS One. 2012;7:e44808.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  21. Kawa S, Hamano H, Kiyosawa K. High serum IgG4 concentrations in patients with sclerosing pancreatitis. Reply. N Engl J Med. 2001;345:148.

    Article  Google Scholar 

  22. Shimosegawa T, Kataoka K, Kamisawa T, Miyakawa H, Ohara H, Ito T, et al. The revised Japanese clinical diagnostic criteria for chronic pancreatitis. J Gastroenterol. 2010;45:584–91.

    Article  PubMed  Google Scholar 

  23. Maruyama M, Arakura N, Ozaki Y, Watanabe T, Ito T, Yoneda S, et al. Type 1 autoimmune pancreatitis can transform into chronic pancreatitis: a long-term follow-up study of 73 Japanese patients. Int J Rheumatol. 2013;2013:8.

    Article  Google Scholar 

  24. Shimosegawa T, Chari ST, Frulloni L, Kamisawa T, Kawa S, Mino-Kenudson M, et al. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas. 2011;40:352–8.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Masahiro Maruyama MD, PhD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Maruyama, M., Arakura, N., Kawa, S. (2015). Development to Chronic Pancreatitis. In: Kamisawa, T., Chung, J. (eds) Autoimmune Pancreatitis. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-55086-7_25

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-55086-7_25

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-55085-0

  • Online ISBN: 978-3-642-55086-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics